Insider Stock Trading History of Sherman Jeffrey W


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Sherman Jeffrey W since year 2005. The trader's CIK number is 1230482. At the time of this reporting, Sherman Jeffrey W is the EVP and Chief Medical Officer of Horizon Pharma Plc . (stock ticker symbol HZNP). See this page for all insider trading activities at Horizon Pharma Plc .

Note that in the past SHERMAN JEFFREY W also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Sherman Jeffrey W since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-02 HZNP Horizon Pharma Plc Option Ex 15,500 .00 0
2017-03-23 HZNP Horizon Pharma Plc Option Ex 19,250 .00 0
2017-01-02 HZNP Horizon Pharma Plc Option Ex 26,750 .00 0
2016-12-16 HZNP Horizon Pharma Plc Option Ex 8,500 2.40 20,400
2016-08-02 HZNP Horizon Pharma Plc Sale 2,900 20.00 58,000
2016-03-23 HZNP Horizon Pharma Plc Option Ex 19,250 .00 0
2016-02-26 HZNP Horizon Pharma Plc Sale 4,100 20.00 82,000
2016-01-02 HZNP Horizon Pharma Plc Option Ex 26,750 .00 0
2015-12-15 HZNP Horizon Pharma Plc Option Ex 30,442 3.68 112,026
2015-12-10 HZNP Horizon Pharma Plc Sale 4,456 20.00 89,120
2015-12-08 HZNP Horizon Pharma Plc Option Ex 8,208 .00 0
2015-09-21 HZNP Horizon Pharma Plc Sale 7,750 31.78 246,295
2015-07-15 HZNP Horizon Pharma Plc Option Ex 26,887 3.68 98,944
2015-07-15 HZNP Horizon Pharma Plc Sale 26,887 35.55 955,832
2014-12-08 HZNP Horizon Pharma Plc Option Ex 8,208 .00 0
2015-01-02 HZNP Horizon Pharma Plc Option Ex 26,750 .00 0
2014-11-19 HZNP Horizon Pharma Plc Sale 24,999 12.05 301,237
2014-05-19 HZNP Horizon Pharma Plc Sale 9,361 12.94 121,131
2013-12-09 HZNP Horizon Pharma Plc Option Ex 8,208 .00 0
2013-01-02 HZNP Horizon Pharma Plc Sale 16,304 2.36 38,477
2012-12-10 HZNP Horizon Pharma Plc Option Ex 8,208 .00 0
2006-09-27 NEOL Neopharm Inc Buy 1,000 4.98 4,980

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sherman Jeffrey W (EVP and Chief Medical Officer of Horizon Pharma Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.